Strumento inattivo

Azioni CardioDx Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

CardioDx : New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus® CAD Blood Test to Help Safely Direct Cardiovascular Care	12/04/17
CardioDx : Announces Results of Study Demonstrating the Benefits of the Corus CAD Gene Expression Test Use in an African American Patient Population	22/10/14
CardioDx : Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test	08/07/14
CardioDx : New Study Results Further Reinforce that the Corus® CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions for Patients with Suspected Obstructive Coronary Artery Disease	08/05/14
CardioDx : and Medison Israel Enter Into an Exclusive Corus® CAD Product Marketing and Sales Agreement	10/04/14

Settore

	Variaz. 1 gen.	Capi.
BIOMÉRIEUX	-9,54%	11,48 Mrd
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7,90%	7,64 Mrd
DIASORIN S.P.A.	+3,99%	5,58 Mrd
LANTHEUS HOLDINGS, INC.	+29,40%	5,49 Mrd
AUTOBIO DIAGNOSTICS CO., LTD.	-15,47%	3,86 Mrd
ANDON HEALTH CO., LTD.	+8,42%	2,61 Mrd
10X GENOMICS, INC.	-64,94%	2,42 Mrd
VITROLIFE AB	-11,45%	2,27 Mrd
MYRIAD GENETICS, INC.	+20,06%	2,1 Mrd